Top compounds associated with response to RNGTT


Feature Type Standardized
Nominal ANOVA
mRNA FK866 CTRPv2 pan-cancer AAC 0.24 6e-09
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-08
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA SR1001 CTRPv2 pan-cancer AAC 0.2 4e-07
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA A-770041 GDSC1000 pan-cancer AAC 0.29 9e-07
Download CSV